Longevity Peptide Research Standards
Longevity peptides target the upstream regulatory mechanisms of aging: telomerase activation (Epithalon), mitochondrial biogenesis (MOTS-C, SS-31), thymic immune restoration (Thymalin, Thymosin Alpha-1), and epigenetic gene expression normalization (Bioregulator peptides). Because these mechanisms operate on weeks-to-months timescales, dosing consistency across an entire protocol is more critical than for acute-use peptides.
Many longevity peptides are researched in microgram quantities on precise cycling schedules. Epithalon, for example, is typically studied in 10-day cycles with doses of 10 mg. NAD+ precursor titration begins at 50 mg and escalates to 100 mg based on tolerance. Each dosing event must be calculated from the same reconstitution parameters to maintain intra-protocol consistency.
All dosing data is cross-referenced against independent analytical lab results. For research use only.